openPR Logo
Press release

Antibody Drug Conjugates (ADCs) Market Analysis, Revenue, Price, Market Share, Growth Rate, Forecast 2026|Pfizer, Novartis, Genmab, Bayer

12-15-2020 09:10 AM CET | Health & Medicine

Press release from: QY Research, Inc

Antibody Drug Conjugates (ADCs) Market Analysis, Revenue,

The global Antibody Drug Conjugates (ADCs) market is broadly analyzed in this report that sheds light on critical aspects such as the vendor landscape, competitive strategies, market dynamics, and regional analysis. The report helps readers to clearly understand the current and future status of the global Antibody Drug Conjugates (ADCs) market. The research study comes out as a compilation of useful guidelines for players to secure a position of strength in the global Antibody Drug Conjugates (ADCs) market. The authors of the report profile leading companies of the global Antibody Drug Conjugates (ADCs) market, such as , Roche, Pfizer, Novartis, Genmab, Bayer, Seattle Genetics, Takeda Pharmaceuticals, AbbVie, AbGenomics, ADC Therapeutics, Astellas Pharma, Kairos Therapeutics They provide details about important activities of leading players in the competitive landscape.

The report predicts the size of the global Antibody Drug Conjugates (ADCs) market in terms of value and volume for the forecast period 2019-2026. As per the analysis provided in the report, the global Antibody Drug Conjugates (ADCs) market is expected to rise at a CAGR of XX % between 2019 and 2026 to reach a valuation of US$ XX million/billion by the end of 2026. In 2018, the global Antibody Drug Conjugates (ADCs) market attained a valuation of US$_ million/billion. The market researchers deeply analyze the global Antibody Drug Conjugates (ADCs) industry landscape and the future prospects it is anticipated to create.

This publication includes key segmentations of the global Antibody Drug Conjugates (ADCs) market on the basis of product, application, and geography (country/region). Each segment included in the report is studied in relation to different factors such as consumption, market share, value, growth rate, and production.

Get Sample Copy of This Report:  https://www.qyresearch.com/sample-form/form/1609807/global-antibody-drug-conjugates-adcs-market

The comparative results provided in the report allow readers to understand the difference between players and how they are competing against each other. The research study gives a detailed view of current and future trends and opportunities of the global Antibody Drug Conjugates (ADCs) market. Market dynamics such as drivers and restraints are explained in the most detailed and easiest manner possible with the use of tables and graphs. Interested parties are expected to find important recommendations to improve their business in the global Antibody Drug Conjugates (ADCs) market.

Readers can understand the overall profitability margin and sales volume of various products studied in the report. The report also provides the forecasted as well as historical annual growth rate and market share of the products offered in the global Antibody Drug Conjugates (ADCs) market. The study on end-use application of products helps to understand the market growth of the products in terms of sales.

Global Antibody Drug Conjugates (ADCs) Market by Product: Seattle Genetics Technology, ImmunoGen Technology, Immunomedics Technology

Global Antibody Drug Conjugates (ADCs) Market by Application: Hospital, Clinics, Others

The report also focuses on the geographical analysis of the global Antibody Drug Conjugates (ADCs) market, where important regions and countries are studied in great detail.

Global Antibody Drug Conjugates (ADCs) Market by Geography:

Methodology

Our analysts have created the report with the use of advanced primary and secondary research methodologies.

As part of primary research, they have conducted interviews with important industry leaders and focused on market understanding and competitive analysis by reviewing relevant documents, press releases, annual reports, and key products.

For secondary research, they have taken into account the statistical data from agencies, trade associations, and government websites, internet sources, technical writings, and recent trade information.

Key questions answered in the report:

What is the growth potential of the Antibody Drug Conjugates (ADCs) market?
Which product segment will grab a lion’s share?
Which regional market will emerge as a frontrunner in the coming years?
Which application segment will grow at a robust rate?
What are the growth opportunities that may emerge in the Antibody Drug Conjugates (ADCs) industry in the years to come?
What are the key challenges that the global Antibody Drug Conjugates (ADCs) market may face in the future?
Which are the leading companies in the global Antibody Drug Conjugates (ADCs) market?
Which are the key trends positively impacting the market growth?
Which are the growth strategies considered by the players to sustain hold in the global Antibody Drug Conjugates (ADCs) market?
Enquire For Customization in the Report: https://www.qyresearch.com/customize-request/form/1609807/global-antibody-drug-conjugates-adcs-market

 Table Of Contents:

Table of Contents 1 Market Overview of Antibody Drug Conjugates (ADCs)
1.1 Antibody Drug Conjugates (ADCs) Market Overview
1.1.1 Antibody Drug Conjugates (ADCs) Product Scope
1.1.2 Market Status and Outlook
1.2 Global Antibody Drug Conjugates (ADCs) Market Size Overview by Region 2015 VS 2020 VS 2026
1.3 Global Antibody Drug Conjugates (ADCs) Market Size by Region (2015-2026)
1.4 Global Antibody Drug Conjugates (ADCs) Historic Market Size by Region (2015-2020)
1.5 Global Antibody Drug Conjugates (ADCs) Market Size Forecast by Region (2021-2026)
1.6 Key Regions Antibody Drug Conjugates (ADCs) Market Size YoY Growth (2015-2026)
1.6.1 North America Antibody Drug Conjugates (ADCs) Market Size YoY Growth (2015-2026)
1.6.2 Europe Antibody Drug Conjugates (ADCs) Market Size YoY Growth (2015-2026)
1.6.3 China Antibody Drug Conjugates (ADCs) Market Size YoY Growth (2015-2026)
1.6.4 Rest of Asia Pacific Antibody Drug Conjugates (ADCs) Market Size YoY Growth (2015-2026)
1.6.5 Latin America Antibody Drug Conjugates (ADCs) Market Size YoY Growth (2015-2026)
1.6.6 Middle East & Africa Antibody Drug Conjugates (ADCs) Market Size YoY Growth (2015-2026) 2 Antibody Drug Conjugates (ADCs) Market Overview by Type
2.1 Global Antibody Drug Conjugates (ADCs) Market Size by Type: 2015 VS 2020 VS 2026
2.2 Global Antibody Drug Conjugates (ADCs) Historic Market Size by Type (2015-2020)
2.3 Global Antibody Drug Conjugates (ADCs) Forecasted Market Size by Type (2021-2026)
2.4 Seattle Genetics Technology
2.5 ImmunoGen Technology
2.6 Immunomedics Technology 3 Antibody Drug Conjugates (ADCs) Market Overview by Type
3.1 Global Antibody Drug Conjugates (ADCs) Market Size by Application: 2015 VS 2020 VS 2026
3.2 Global Antibody Drug Conjugates (ADCs) Historic Market Size by Application (2015-2020)
3.3 Global Antibody Drug Conjugates (ADCs) Forecasted Market Size by Application (2021-2026)
3.4 Hospital
3.5 Clinics
3.6 Others 4 Global Antibody Drug Conjugates (ADCs) Competition Analysis by Players
4.1 Global Antibody Drug Conjugates (ADCs) Market Size (Million US$) by Players (2015-2020)
4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibody Drug Conjugates (ADCs) as of 2019)
4.3 Date of Key Manufacturers Enter into Antibody Drug Conjugates (ADCs) Market
4.4 Global Top Players Antibody Drug Conjugates (ADCs) Headquarters and Area Served
4.5 Key Players Antibody Drug Conjugates (ADCs) Product Solution and Service
4.6 Competitive Status
4.6.1 Antibody Drug Conjugates (ADCs) Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans 5 Company (Top Players) Profiles and Key Data
5.1 Roche
5.1.1 Roche Profile
5.1.2 Roche Main Business and Company’s Total Revenue
5.1.3 Roche Products, Services and Solutions
5.1.4 Roche Revenue (US$ Million) (2015-2020)
5.1.5 Roche Recent Developments
5.2 Pfizer
5.2.1 Pfizer Profile
5.2.2 Pfizer Main Business and Company’s Total Revenue
5.2.3 Pfizer Products, Services and Solutions
5.2.4 Pfizer Revenue (US$ Million) (2015-2020)
5.2.5 Pfizer Recent Developments
5.3 Novartis
5.5.1 Novartis Profile
5.3.2 Novartis Main Business and Company’s Total Revenue
5.3.3 Novartis Products, Services and Solutions
5.3.4 Novartis Revenue (US$ Million) (2015-2020)
5.3.5 Genmab Recent Developments
5.4 Genmab
5.4.1 Genmab Profile
5.4.2 Genmab Main Business and Company’s Total Revenue
5.4.3 Genmab Products, Services and Solutions
5.4.4 Genmab Revenue (US$ Million) (2015-2020)
5.4.5 Genmab Recent Developments
5.5 Bayer
5.5.1 Bayer Profile
5.5.2 Bayer Main Business and Company’s Total Revenue
5.5.3 Bayer Products, Services and Solutions
5.5.4 Bayer Revenue (US$ Million) (2015-2020)
5.5.5 Bayer Recent Developments
5.6 Seattle Genetics
5.6.1 Seattle Genetics Profile
5.6.2 Seattle Genetics Main Business and Company’s Total Revenue
5.6.3 Seattle Genetics Products, Services and Solutions
5.6.4 Seattle Genetics Revenue (US$ Million) (2015-2020)
5.6.5 Seattle Genetics Recent Developments
5.7 Takeda Pharmaceuticals
5.7.1 Takeda Pharmaceuticals Profile
5.7.2 Takeda Pharmaceuticals Main Business and Company’s Total Revenue
5.7.3 Takeda Pharmaceuticals Products, Services and Solutions
5.7.4 Takeda Pharmaceuticals Revenue (US$ Million) (2015-2020)
5.7.5 Takeda Pharmaceuticals Recent Developments
5.8 AbbVie
5.8.1 AbbVie Profile
5.8.2 AbbVie Main Business and Company’s Total Revenue
5.8.3 AbbVie Products, Services and Solutions
5.8.4 AbbVie Revenue (US$ Million) (2015-2020)
5.8.5 AbbVie Recent Developments
5.9 AbGenomics
5.9.1 AbGenomics Profile
5.9.2 AbGenomics Main Business and Company’s Total Revenue
5.9.3 AbGenomics Products, Services and Solutions
5.9.4 AbGenomics Revenue (US$ Million) (2015-2020)
5.9.5 AbGenomics Recent Developments
5.10 ADC Therapeutics
5.10.1 ADC Therapeutics Profile
5.10.2 ADC Therapeutics Main Business and Company’s Total Revenue
5.10.3 ADC Therapeutics Products, Services and Solutions
5.10.4 ADC Therapeutics Revenue (US$ Million) (2015-2020)
5.10.5 ADC Therapeutics Recent Developments
5.11 Astellas Pharma
5.11.1 Astellas Pharma Profile
5.11.2 Astellas Pharma Main Business and Company’s Total Revenue
5.11.3 Astellas Pharma Products, Services and Solutions
5.11.4 Astellas Pharma Revenue (US$ Million) (2015-2020)
5.11.5 Astellas Pharma Recent Developments
5.12 Kairos Therapeutics
5.12.1 Kairos Therapeutics Profile
5.12.2 Kairos Therapeutics Main Business and Company’s Total Revenue
5.12.3 Kairos Therapeutics Products, Services and Solutions
5.12.4 Kairos Therapeutics Revenue (US$ Million) (2015-2020)
5.12.5 Kairos Therapeutics Recent Developments 6 North America Antibody Drug Conjugates (ADCs) by Players and by Application
6.1 North America Antibody Drug Conjugates (ADCs) Market Size and Market Share by Players (2015-2020)
6.2 North America Antibody Drug Conjugates (ADCs) Market Size by Application (2015-2020) 7 Europe Antibody Drug Conjugates (ADCs) by Players and by Application
7.1 Europe Antibody Drug Conjugates (ADCs) Market Size and Market Share by Players (2015-2020)
7.2 Europe Antibody Drug Conjugates (ADCs) Market Size by Application (2015-2020) 8 China Antibody Drug Conjugates (ADCs) by Players and by Application
8.1 China Antibody Drug Conjugates (ADCs) Market Size and Market Share by Players (2015-2020)
8.2 China Antibody Drug Conjugates (ADCs) Market Size by Application (2015-2020) 9 Rest of Asia Pacific Antibody Drug Conjugates (ADCs) by Players and by Application
9.1 Rest of Asia Pacific Antibody Drug Conjugates (ADCs) Market Size and Market Share by Players (2015-2020)
9.2 Rest of Asia Pacific Antibody Drug Conjugates (ADCs) Market Size by Application (2015-2020) 10 Latin America Antibody Drug Conjugates (ADCs) by Players and by Application
10.1 Latin America Antibody Drug Conjugates (ADCs) Market Size and Market Share by Players (2015-2020)
10.2 Latin America Antibody Drug Conjugates (ADCs) Market Size by Application (2015-2020) 11 Middle East & Africa Antibody Drug Conjugates (ADCs) by Players and by Application
11.1 Middle East & Africa Antibody Drug Conjugates (ADCs) Market Size and Market Share by Players (2015-2020)
11.2 Middle East & Africa Antibody Drug Conjugates (ADCs) Market Size by Application (2015-2020) 12 Antibody Drug Conjugates (ADCs) Market Dynamics
12.1 Industry Trends
12.2 Market Drivers
12.3 Market Challenges
12.4 Porter’s Five Forces Analysis 13 Research Finding /Conclusion 14 Methodology and Data Source
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
14.4 Author List

Contact US:
QY Research, INC.
17890 Castleton,
Suite 218,
City of industry, CA – 91748
USA: +1 626 295 2442
Email: enquiry@qyresearch.com
Web: http://www.qyresearch.com

About Us:

QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.”

 

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Antibody Drug Conjugates (ADCs) Market Analysis, Revenue, Price, Market Share, Growth Rate, Forecast 2026|Pfizer, Novartis, Genmab, Bayer here

News-ID: 2209945 • Views:

More Releases from QY Research, Inc

Global High Pressure Commercial Toilet Market Insights - Industry Share, Sales Projections, and Demand Outlook 2024-2030-KRBL,LT FOODS,REI Agro
Global High Pressure Commercial Toilet Market Insights - Industry Share, Sales P …
High Pressure Commercial Toilet also means pressure-flushing toilets. Pressure-flushing toilets are especially common in cities in the U.S. The ceramic tank is not used as a water tank. It holds a plastic pressure vessel of maybe one-third to one-half the ceramic tank"s volume. That pressure tank contains a sealed air bladder. When the tank is filled from the water supply line, the tank fills with water until the air bladder
Global Twin-Screw Pumps Market Insights - Industry Share, Sales Projections, and Demand Outlook 2024-2030-ABB Ltd,GE Grid Solutions,Schneider Electric
Global Twin-Screw Pumps Market Insights - Industry Share, Sales Projections, and …
Twin-Screw Pumps is a displacement pump consisting of a casing containing two parallel screws with intermeshing threads fitted to prevent backward movement of fluid The global Twin-Screw Pumps market was valued at US$ 503 million in 2023 and is anticipated to reach US$ 629 million by 2030, witnessing a CAGR of 3.3% during the forecast period 2024-2030. The top five global producers of twin-screw pumps are Colfax, ITT Bornemann, Flowserve, SPX Flow
Global Strain Gauge Sensors Market Insights - Industry Share, Sales Projections, and Demand Outlook 2024-2030-Kohler,Zurn Industries,Western Pottery
Global Strain Gauge Sensors Market Insights - Industry Share, Sales Projections, …
A strain gauge (or strain gage) is a sensor whose resistance varies with applied force; it converts force, pressure, tension, weight, etc., into a change in electrical resistance which can then be measured. When external forces are applied to a stationary object, stress and strain are the result. Stress is defined as the object"s internal Strain Gauge forces, and strain is defined as the displacement and deformation that occur. The global
Global Automatic Soap Dispensers Market Insights - Industry Share, Sales Projections, and Demand Outlook 2024-2030-Colfax,ITT Bornemann,Flowserve
Global Automatic Soap Dispensers Market Insights - Industry Share, Sales Project …
Automatic soap dispensers (also known as touchless or no-touch soap dispensers) dispense a controlled amount of soap solution (or a similar liquid such as a hand sanitizer). They are often used in conjunction with automatic faucets in public restrooms. They function to conserve the amount of soap used and stem infectious disease transmission. The global Automatic Soap Dispensers market was valued at US$ million in 2023 and is anticipated to reach

All 5 Releases


More Releases for ADC

ADC Market: Transforming Cancer Treatment
The global market for antibody-drug conjugates (ADCs) was valued at US$ 11.32 billion in 2023 and is expected to reach US$ 27.37 billion by 2033, growing at a compound annual growth rate (CAGR) of 9.23% from 2024 to 2033. This growth is primarily driven by the increasing prevalence of cancer and the growing demand for safe and effective treatments. Antibody Drug Conjugates: A Growing Force in Cancer Treatment and Market Expansion Key
With Knockout ADC Innovations, Creative Biolabs Took Center Stage at the 2024 Wo …
Creative Biolabs wrapped up a successful show at the 15th Annual World ADC San Diego in the beginning of November, where its third year of participation, highlighting its dedication to the advancement of antibody-drug conjugate (ADC) technology. New York, USA - November 13, 2024 - Creative Biolabs seized the spotlight at Booth 313 by offering groundbreaking solutions across the entire ADC development spectrum, which demonstrate their unrivaled expertise and dedication to
Showing Off Their ADC Game: Creative Biolabs Hits the 15th Annual World ADC Summ …
From November 4, Creative Biolabs will be back at the 15th Annual World ADC Summit in San Diego, marking its fourth year at the leading global gathering featuring innovative conjugates. New York, USA - November 6, 2024 - Creative Biolabs invites all ADC enthusiasts, from new entrants to seasoned experts, to explore its comprehensive suite of ADC solutions and experience the latest in antibody-drug conjugate (ADC) innovation at Booth #313. Image: https://www.getnews.info/uploads/0c59d26f78bf6dd58aafee5bc68d7d8c.jpg "2023
ADC Drugs For Breast Cancer Treatment
Breast cancer is the malignant tumor with the highest morbidity and mortality among women worldwide. At present, the main therapeutic methods include surgery, chemotherapy, radiotherapy, endocrine therapy and targeted therapy, etc. The development and marketing of new drugs have far-reaching significance in improving the survival of breast cancer patients and changing the pattern of breast cancer treatment. On February 24, 2023, The NMPA approved Enhertu, an injectable drug developed jointly by
Analog-to-Digital Converters Market by Product (Ramp ADC, Integrating ADC, Succe …
Analog-to-Digital Converters Market by Product (Ramp ADC, Integrating ADC, Successive Approximation ADC, Delta-sigma ADC, and Others (Pipelined/Flash ADC)), and Application (Consumer Electronics and Industrial) - Global Opportunity Analysis and Industry Forecast, 2017-2023 Full Report : https://www.alliedmarketresearch.com/analog-to-digital-converters-market Increasing disposable income and technological advancements supplement the analog-to-digital converters market. However, complex design of the ADC hampers this market growth. On the other hand, encouragement in digitization of work processes by government in emerging economies,
Global Data Converters Market Report 2017 (Analog to Digital Converter, Current …
The research report titled Global Data Converters Sales Market Report 2017 market size and forecast and overview on current market trends. This report studies sales (consumption) of Global Data Converters Market 2017, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering National Semiconductor Nippon Precision Circuits Inc Micro Analog systems Microchip Technology. TelCom Semiconductor, Inc Vishay Siliconix Texas